M. Sedgwick

Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris.

S. Cobbe, H. Rasmussen, M. Sedgwick, 1992, The American journal of cardiology.

Pharmacokinetic and pharmacodynamic effects of UK-68,798, a new potential class III antiarrhythmic drug.

D. Walker, S. Cobbe, H. Rasmussen, 1991, British journal of clinical pharmacology.

Effects of the new class III antiarrhythmic drug dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris.

S. Cobbe, A. Rae, I. Dalrymple, 1995, European heart journal.

Efficacy of out of hospital defibrillation by ambulance technicians using automated external defibrillators. The Heartstart Scotland Project.

S. Cobbe, D. Carrington, M. Sedgwick, 1992, Resuscitation.

Chemical cardioversion of atrial fibrillation with intravenous dofetilide.

S. Cobbe, G. Lip, A. Rae, 1995, International journal of cardiology.

Performance of an established system of first responder out-of-hospital defibrillation. The results of the second year of the Heartstart Scotland Project in the 'Utstein Style'.

S M Cobbe, S. Cobbe, M L Sedgwick, 1993, Resuscitation.

Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris.

S. Cobbe, S. Cobbe, H. Rasmussen, 1992, The American journal of cardiology.

The causative rhythm in out-of-hospital cardiac arrests witnessed by the emergency medical services in the Heartstart Scotland Project.

S. Cobbe, D. Carrington, M. Sedgwick, 1994, Resuscitation.